from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2367c/-

LFCtreatmentdescriptionclass of inhibitor

-1.337

Amikacinug/mL Amikacintranslation

-1.026

Cap5-10ug/mL Capreomycintranslation

-0.878

Rox10-50 ug/mL Roxithromycintranslation

-0.007

SM2-5 ug/mL Streptomycintranslation

-2.090

Tet5-10 ug/mL Tetracyclinetranslation

0.102

Rif0.2-5ug/mL Rifampicintranscription

-0.242

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.350

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.589

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.696

CPZ10-50 ug/mL Chlorpromazinerespiration

1.479

Clofazimine10-13 ug/mL Clofaziminerespiration

0.009

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.590

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.675

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.996

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.556

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.777

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.165

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.289

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.083

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.376

KCN5-20 ug/mL Potassium cyaniderespiration

0.250

NaN30.2-2 mM Sodium aziderespiration

0.170

Nigericin50 uM Nigericinrespiration

0.306

TRC10-150 ug/mL Triclosanrespiration

0.180

TRZ10-25 ug/mL Thioridazinerespiration

-0.130

Valinomycin0.5-10 uM Valinomycinrespiration

0.125

ZnSO42 mM ZnSO4respiration

-0.241

menadione6-10 ug/mL Menadionerespiration

0.415

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.399

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.249

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.170

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.194

NRP_1Non-replicating persistence stage 1dosRassociated

-0.001

Amp0.2mg/mL AmpicillincellWall

-0.276

Cephalexin20-100 ug/mL CephalexincellWall

-0.382

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.017

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.211

EMB10-20 ug/mL EthambutolcellWall

0.293

Eta12-40 ug/mL EthionamidecellWall

0.613

INH0.2-0.4 ug/mL IsoniazidcellWall

0.100

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.637

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.637

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.626

BZA0.12 mg/mL BenzamidearomaticAmides

-0.662

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.441

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.864

H2O24 mM hydrogen peroxideDNAdamaging

-0.292

Levo10 ug/mL LevofloxacinDNAdamaging

-1.017

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.031

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.281

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.634

UVUV-irradiationDNAdamaging

0.184

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.356

Antimycin12.5-50 ug/mL Antimycin A?

-0.376

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.041

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.009

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.503

PA8240.2-2 ug/mL PA-824?

2.171

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.428

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.318

Verapamil50 uM Verapamil?

-0.019

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.059

methoxatin10-20 ug/mL Methoxatin?